Open original FDA record ↗Recall record
- FDA identifier
- Z-1772-2026
- Company in FDA record
- Beckman Coulter, Inc.
- FDA classification date
- Apr 3, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to a manufacturing issue - missing a drug in well 4/4 but contain double the amount of antibiotics
Source facts
- Action
- On 07/15/2024, firm sent via mail/email an "URGENT MEDICAL DEVICE RECALL" Letter to customer inform them that customers have reported multiple patient samples with skipped wells for Ceftolozane/Tazobactam (C/T) when tested with MicroScan Neg MIC 3J Lot 2025-08-23. The C/T 2/4 dilution well exhibited no growth while growth was observed in the C/T 4/4 well. Customers are instructed to: "Discontinue use of this lot and discard per your laboratory guidelines. "Consider reviewing the C/T antimicrobial susceptibility test results from this lot if Enterobacterales reported as resistant and P. aeruginosa reported as intermediate or if an increasing trend in resistance has been observed for C/T in your laboratory. "The laboratory should retain the inventory of other MicroScan Neg MIC 3J lots as they are not impacted by this issue. any questions regarding this notice, please contact us: "From our website: http://www.beckmancoulter.com "By phone: please contact: Customer call center TEL :0120-566-730
- Initiated
- 2025-06-25
- Root cause
- Process control
- Distribution
- International distribution in the country of Japan.
- Recall number
- Z-1772-2026
- Recall status
- Open, Classified
- CDRH record ID
- 219075
- FDA classified
- 2026-04-03
- Recall event number
- 98553